Raphaël De Coninck

Primary location

143 Avenue Louise
1050 Brussels
Belgium

Raphaël De Coninck

Vice President

Dr. Raphaël De Coninck heads CRA’s Brussels office. Raphaël provides expert economic evidence and testimony in all competition matters, leading teams of economists at the forefront of merger, antitrust and damages analysis. He has worked on many of the landmark European competition cases of the last two decades, including over 80 mergers and 25 “Phase II” merger investigations, and over 50 abuse of dominance, cartel and damages cases.

Raphaël advises clients in competition matters in front of the European Commission and national authorities, as well as in litigation and in arbitration. In addition to European cases, he has provided expert economic evidence in Belgium, the United Kingdom, France, the Netherlands, Spain and Switzerland, and regularly works on transatlantic cases in close collaboration with US colleagues.

Raphaël’s experience spans a wide range of products and industries, including in the technology sector, pharmaceuticals, consumer products and retail, transport, telecoms, energy, basic industries, financial services, media and entertainment. While at CRA, he has worked for clients such as leading tech firms, Universal Music Group, Dolby, Pfizer, Novartis, Mylan, Baxter, Abbott, GE, Linde, Novelis, Energizer, Danone, Henkel, L’Oréal, ABF, Ahold Delhaize, Virgin Atlantic, Wallenius, Cable Europe, Canal+, SFR, FIFA, Credit Suisse, Deutsche Bank, JP Morgan, private equity firms and the European Commission.

Prior to joining CRA, Raphaël was a member of DG Competition’s chief economist team at the European Commission. While at the Commission, he contributed to major competition policy initiatives, including the European Commission’s Best Practices for Economic Submissions and Data Collection in Merger and Antitrust Cases, and the European Commission’s Practical Guide on the Quantification of Antitrust Damages. Raphaël has published numerous articles on the economics of competition, covering in particular horizontal and non-horizontal mergers, the impact of mergers on innovation, market definition, exclusionary conduct, excessive prices, standard essential patents, bargaining power and antitrust damages estimation.

Raphaël holds a PhD in economics from the University of Chicago and degrees in law and in economics from the University of Liège, Belgium. He has been a post-doctoral fellow at New York University and taught at the University of Chicago and the Free University of Brussels (ULB).

Raphaël is recognized as one of Europe’s top competition economists by WWL Global Elite, receiving wide praise from clients and peers: “Raphaël De Coninck is a “superb” economist who is recommended for his “really excellent work” when it comes to delivering expert testimony on competition-related merger and damages cases.”

Education

  • Ph.D. Economics, University of Chicago
  • M.A. Economics, University of Chicago
  • Licence Law, University of Liège
  • Licence Economics, University of Liège

Cases

European Commission unconditionally approves INEOS’ acquisition of certain assets of TotalEnergies

Read More

DFDS

Read More

Biscuit International / Continental Bakeries

Read More

United Group / Wind Hellas

Read More

AerCap/GECAS

Read More

Consignor/Unifaun

Read More

Car shipping follow-on litigation (UK)

Read More

Mylan/Upjohn

Read More

Big 4

Read More

RoRo Shipping (US)

Read More

Credit Suisse

Read More

Proximus

Read More

Flynn/Pfizer

Read More

Dossche Mills / Ceres

Read More

Novelis/Aleris

Read More

Biscuit International/Aviateur

Read More

Aperam/VDM

Read More

TEVA/Mylan

Read More

Energizer/Spectrum Brands

Read More

Praxair/Linde

Read More

Infrabel

Read More

Phenytoin Sodium

Read More

Immoweb (MFNs)

Read More

Ahold/Delhaize

Read More

Danone/White Wave

Read More

Reichhold/Polynt

Read More

Abbott/Alere

Read More

Google

Read More

Kineopolis/Utopolis

Read More

European Commission clears Commscope/TE Connectivity transaction in Phase I

Read More

Events

Standard Essential Patents: should licences be available at any point in the value chain?

Read More

Concurrences Law & Economics Webinar: The Aspen Decision

Read More

IBA Annual Conference Seoul 2019

Read More

Brussels School of Competition Seminar

Read More

News Articles

European Commission unconditionally approves INEOS’ acquisition of certain assets of TotalEnergies

Read More

European Commission closes investigations into retail alliances

Read More

European Commission closes antitrust investigation into wood pulp

Read More

European Commission closes antitrust investigation of royalty-free licensing policy for SEPs

Read More

The Consortia Block Exemption Regulation (CBER) set to expire in April 2024

Read More

CMA accepts commitments from P&O Ferries Holdings Limited and DFDS A/S

Read More

European Commission clears Biscuit International’s expansion

Read More

European Commission clears United Group/Wind Hellas

Read More

Standard Essential Patents: should licences be available at any point in the value chain?

Read More

EC clears AerCap’s $30 billion acquisition of GECAS

Read More

EC unconditionally clears joint venture including Consignor and Unifaun

Read More

EC clears Mylan/Upjohn merger

Read More

Biscuit International’s acquisition of Aviateur cleared

Read More

EC clears Novelis’ $2.6 billion acquisition of Aleris, subject to conditions

Read More

EC approves Danone’s $10.4 billion acquisition of WhiteWave

Read More

Belgian movie theatre merger cleared in Phase II

Read More

Ahold/Delhaize merger cleared in Europe

Read More

Paris Court of Appeal overturns Google abuse of dominance ruling

Read More

Publications

Big tech acquisitions and innovation incentives

Read More

Pivotality: A sound new theory of harm in horizontal mergers?

Read More

Mergers: How to measure local Competition

Read More

Transparency, Predictability, and Efficiency of SSO-based Standardization and SEP Licensing

Read More

Innovation in EU Merger control: in need of a consistent framework

Read More

Excessive pricing cases in the pharmaceutical industry

Read More

Mergers and bargaining power: back to the future? Insights from the Universal/EMI merger

Read More